Skip to content
New: Acetyl-L-Carnitine Benefits: The Real Evidence

Supplements

Fisetin: Benefits, Senolytics, and the Mitochondrial Angle

MitoHacker·Updated July 7, 2026·3 min read
Share:

Community Consensus

Do you like Fisetin?

Reflects reader sentiment, not medical advice or a recommendation.

Quick answer

Fisetin is a flavonoid found in strawberries, apples, and persimmons that is being studied as a senolytic, a compound that helps clear worn-out senescent cells. Because senescent cells are marked by dysfunctional mitochondria, removing them may relieve inflammation and improve tissue function. A 2018 Mayo Clinic study found fisetin reduced senescent cells and extended lifespan in aged mice, but human senolytic trials are still ongoing and benefits in people are not yet proven.

Key takeaways

  • Fisetin is a dietary flavonoid best known as one of the most promising natural senolytics.
  • Senescent 'zombie' cells carry dysfunctional mitochondria, so clearing them is a different anti-aging strategy than tuning up existing cells.
  • The strongest evidence is a mouse study that extended lifespan; human clinical trials are ongoing and early.
  • Fisetin is generally considered a more potent standalone senolytic than quercetin among common dietary flavonoids.
  • Plain fisetin is poorly absorbed, and research doses are far higher than you can get from food.

What fisetin is

Fisetin is a flavonoid, a plant polyphenol found in strawberries, apples, persimmons, grapes, and onions. It has been studied for decades as an antioxidant, but the reason it is having a moment is different: fisetin is one of the most promising senolytics, compounds that help the body clear out worn-out “zombie” cells. That link to cellular aging is what connects it to mitochondrial health.

Senescent cells, and the mitochondrial connection

As tissues age, some cells stop dividing but refuse to die. These senescent cells linger, pump out inflammatory signals (the “SASP”), and drag down the tissue around them. A hallmark of a senescent cell is dysfunctional mitochondria: they run inefficiently, leak more reactive oxygen species, and lose the ability to be cleared by normal quality control. Clearing these cells is thought to relieve that low-grade inflammation and let healthier, better-powered cells take over.

Senolytics attack aging from a different angle than the mitochondria-support supplements. Instead of tuning up existing cells, they remove the damaged ones. Fisetin, urolithin A, and spermidine each work on a different part of that cellular housekeeping story.

What the research actually shows

The headline study came from the Mayo Clinic in 2018, where fisetin reduced senescent cell burden in aged mice and extended both median and maximum lifespan, even when started late in life. In lab and animal models it also shows antioxidant, anti-inflammatory, and neuroprotective effects.

⚠ CLAIM (wellness): Fisetin extended lifespan and reduced senescent cells in aged mice, and human senolytic trials are underway; human benefits are not yet proven. Basis: Yousefzadeh et al., EBioMedicine 2018; ongoing Mayo Clinic trials. Lane: educational.

The honest caveat: the strong evidence is in mice, not people. Human clinical trials of fisetin as a senolytic are ongoing (including studies in frailty and age-related conditions), but results are early and far from conclusive. Fisetin is a genuinely exciting research compound, not a proven anti-aging therapy.

Fisetin vs quercetin

People often compare the two because both are senolytic flavonoids and both appear in senolytic research protocols. Quercetin is usually paired with the drug dasatinib in trials, while fisetin has shown senolytic activity on its own in animal work and is generally considered the more potent senolytic of the common dietary flavonoids. They are complementary rather than interchangeable.

Food sources

Food Relative fisetin content
Strawberries Highest common dietary source
Apples Moderate
Persimmons Moderate
Grapes, onions, cucumber Lower

The catch: the doses used in senolytic research are far higher than you can eat. Getting a “research-level” amount from strawberries alone is not realistic, which is why the trials use concentrated supplements.

Supplements and the absorption problem

Like many flavonoids, plain fisetin is poorly absorbed and cleared quickly. Supplement makers try to solve this with liposomal delivery, fat pairings, or formulations combined with other polyphenols. Research senolytic protocols also tend to use an intermittent “hit and run” dosing pattern (short bursts rather than daily use), on the logic that you only need to periodically clear senescent cells, not suppress them continuously. That intermittent approach is still being worked out in humans.

Safety

Fisetin has a long history of safe dietary intake as a normal food component, and short-term supplement studies report good tolerability. Long-term human safety data at senolytic doses is limited. As a polyphenol it can interact with drug-metabolizing enzymes, so it is worth flagging to a clinician if you take medication.

The bottom line

Fisetin is one of the most compelling senolytic candidates in aging research, with a strong mouse lifespan result and a plausible mitochondrial rationale: clear the damaged, poorly powered cells and let healthier ones work. But the human evidence is still being written. Treat it as a high-interest research compound to watch, not a settled protocol. For the broader picture of supporting healthy mitochondria, see the mitochondrial supplement guide.

Educational information only, not medical advice, and not evaluated by the FDA. Check with a clinician before supplementing, especially if you take medication or have a health condition.

Frequently asked questions

What is fisetin good for?

Fisetin is studied as an antioxidant and, more notably, as a senolytic that helps clear senescent cells linked to aging and inflammation. In aged mice it reduced senescent cell burden and extended lifespan. Human benefits are still being researched and are not yet proven. This is educational information, not medical advice.

Is fisetin better than quercetin?

Both are senolytic flavonoids. Fisetin has shown senolytic activity on its own in animal studies and is generally considered the more potent of the two, while quercetin is usually paired with the drug dasatinib in trials. They are complementary rather than interchangeable.

What foods contain fisetin?

Strawberries are the richest common dietary source, followed by apples, persimmons, grapes, onions, and cucumber. However, the doses used in senolytic research are far higher than you can realistically eat, which is why trials use concentrated supplements.

Is fisetin safe to take?

As a normal food component, fisetin has a long history of safe dietary intake, and short-term supplement studies report good tolerability. Long-term human safety data at senolytic doses is limited, and as a polyphenol it can affect drug metabolism, so check with a clinician if you take medication.

References

  1. 1.Yousefzadeh MJ, et al. Fisetin is a senotherapeutic that extends health and lifespan. EBioMedicine. 2018;36:18-28.
  2. 2.Kirkland JL, Tchkonia T. Senolytic drugs: from discovery to translation. J Intern Med. 2020;288(5):518-536.
  3. 3.Zhu Y, et al. New agents that target senescent cells: the flavone fisetin and the BCL-XL inhibitors A1331852 and A1155463. Aging. 2017;9(3):955-963.
  4. 4.Grynkiewicz G, Demchuk OM. New perspectives for fisetin. Front Chem. 2019;7:697.

Keep reading

Supplements

Acetyl-L-Carnitine Benefits: The Real Evidence

Acetyl-L-carnitine, sold as ALCAR, is L-carnitine with an acetyl group attached, and that single modification is why it exists as a separate product: it crosses the blood-brain barrier more readily than plain L-carnitine. The strongest human evidence is in peripheral neuropathy and depressive symptoms. Two 52-week randomised placebo-controlled trials in 1,257 patients with diabetic neuropathy found improved sural nerve fibre numbers, regenerating fibre clusters, pain and vibratory perception at 1,000 mg three times daily, with more benefit in patients treated earlier. A meta-analysis of 12 trials in 791 participants found reduced depressive symptoms, comparable to standard antidepressants with fewer side effects. It is weakest at the two things it is most often sold for. The dementia trials did not deliver despite a strong acetylcholine mechanism, and a Cochrane review found insufficient evidence to recommend it. Most importantly, in 409 women receiving taxane chemotherapy, 3,000 mg/day of ALCAR made neuropathy significantly worse than placebo, and the effect was still present at 104 weeks. That result means ALCAR should be treated as a compound with specific indications, not a general nerve or brain supplement.

Read →

Supplements

L-Carnitine Side Effects: What Actually Happens

At ordinary supplement doses most people tolerate L-carnitine well. The side effects that do appear are dose-dependent: nausea, abdominal cramping and diarrhoea, plus a fishy body, breath and urine odour that surprises people because it is not an allergy or a bad batch. Gut bacteria convert unabsorbed carnitine into trimethylamine, which smells like rotting fish and leaves the body through sweat and breath, so a shower does not fix it. It is dose-related and fully reverses on stopping. A published risk assessment put the observed safe level at 2,000 mg per day. Four situations deserve real caution rather than a shrug: an existing seizure disorder, thyroid treatment, warfarin, and impaired kidney function. L-carnitine acts as a peripheral antagonist of thyroid hormone, which is why it works against levothyroxine treatment. One question is genuinely unresolved: gut bacteria convert carnitine to TMAO, which accelerated atherosclerosis in mice, while pooled human trials in cardiac patients found lower mortality. Both findings stand. Unusually for a supplement, the certificate of analysis that matters most here confirms isomeric identity rather than potency, because the D-isomer competitively interferes with L-carnitine transport.

Read →

Supplements

How Much Alpha-Lipoic Acid Per Day, and When to Take It

The reference figure is 600 mg per day, and it comes from SYDNEY 2, a trial that compared 600, 1,200 and 1,800 mg of oral alpha-lipoic acid head to head. All three doses improved symptom scores by almost exactly the same amount, roughly 48 to 52 percent against 32 percent on placebo, while nausea, vomiting and vertigo rose steadily with dose. The authors concluded 600 mg once daily gave the best risk-to-benefit ratio, which is why nearly every capsule sold holds that amount. On timing, take it on an empty stomach, about 30 minutes before a meal or two hours after: food both delays and reduces absorption, and alpha-lipoic acid already starts from only about 30 percent absolute bioavailability because the liver extracts most of a dose on first pass. The hour of day matters far less than being fasted, which is the real reason bedtime dosing is popular. Two caveats matter. Those trials studied people with diabetic polyneuropathy, so applying the number to general wellness use is an extrapolation, and the four-year NATHAN 1 trial at 600 mg daily missed its primary endpoint.

Read →